Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans

It is well established that somatic genomic changes can influence phenotypes in cancer, but the role of adaptive changes in developmental disorders is less well understood. Here we have used next-generation sequencing approaches to identify de novo heterozygous mutations in sterile &agr; motif domain–containing protein 9 (SAMD9, located on chromosome 7q21.2) in 8 children with a multisystem disorder termed MIRAGE syndrome that is characterized by intrauterine growth restriction (IUGR) with gonadal, adrenal, and bone marrow failure, predisposition to infections, and high mortality. These mutations result in gain of function of the growth repressor product SAMD9. Progressive loss of mutated SAMD9 through the development of monosomy 7 (–7), deletions of 7q (7q–), and secondary somatic loss-of-function (nonsense and frameshift) mutations in SAMD9 rescued the growth-restricting effects of mutant SAMD9 proteins in bone marrow and was associated with increased length of survival. However, 2 patients with –7 and 7q– developed myelodysplastic syndrome, most likely due to haploinsufficiency of related 7q21.2 genes. Taken together, these findings provide strong evidence that progressive somatic changes can occur in specific tissues and can subsequently modify disease phenotype and influence survival. Such tissue-specific adaptability may be a more common mechanism modifying the expression of human genetic conditions than is currently recognized.

[1]  Deborah Nickerson,et al.  Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L. , 2016, American journal of human genetics.

[2]  H. Okano,et al.  SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7 , 2016, Nature Genetics.

[3]  Lin Wu,et al.  miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9 , 2015, Oncology letters.

[4]  F. Baş,et al.  Rare Causes of Primary Adrenal Insufficiency: Genetic and Clinical Characterization of a Large Nationwide Cohort , 2015, The Journal of clinical endocrinology and metabolism.

[5]  A. Duncan,et al.  DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease , 2015, Best practice & research. Clinical endocrinology & metabolism.

[6]  Ya-Li Yao,et al.  Loading of PAX3 to Mitotic Chromosomes Is Mediated by Arginine Methylation and Associated with Waardenburg Syndrome* , 2015, The Journal of Biological Chemistry.

[7]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[8]  Ting Gong,et al.  Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer. , 2014, Biochemical and biophysical research communications.

[9]  H. Honda,et al.  −7/7q− syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity , 2014, Oncogene.

[10]  Benjamin S. Freedman,et al.  Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. , 2014, Journal of the American Society of Nephrology : JASN.

[11]  P. Koopman,et al.  Building the mammalian testis: origins, differentiation, and assembly of the component cell populations , 2013, Genes & development.

[12]  T. Suda,et al.  Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7. , 2013, Cancer cell.

[13]  G. McFadden,et al.  Evolution and divergence of the mammalian SAMD9/SAMD9L gene family , 2013, BMC Evolutionary Biology.

[14]  J. Uitto,et al.  Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis , 2012, Experimental dermatology.

[15]  S. Nelson,et al.  Mutations in the PCNA-binding domain of CDKN1C cause IMAGE Syndrome , 2012, Nature Genetics.

[16]  J. Scheys,et al.  Evidence of adrenal failure in aging Dax1-deficient mice. , 2011, Endocrinology.

[17]  C. Niemeyer,et al.  Advances in the prognostication and management of advanced MDS in children , 2011, British journal of haematology.

[18]  J. Uitto,et al.  The Samd9L gene: transcriptional regulation and tissue-specific expression in mouse development. , 2011, The Journal of investigative dermatology.

[19]  R. Jaffe,et al.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. , 2011, Endocrine reviews.

[20]  O. Sarig,et al.  Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis. , 2011, The Journal of investigative dermatology.

[21]  Bernhard M. Schuldt,et al.  A bioinformatic assay for pluripotency in human cells , 2011, Nature Methods.

[22]  S. Kulkarni,et al.  Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features suggestive of dyskeratosis congenita and IMAGe association , 2010, Pediatric blood & cancer.

[23]  Y. Olshanskaya,et al.  Myelodysplastic syndrome with monosomy 7 in a patient with XY gonadal dysgenesis (incomplete testicular feminization). , 2009, Cancer genetics and cytogenetics.

[24]  T. Inaba,et al.  Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome. , 2009, Biochemical and biophysical research communications.

[25]  Mark George Thomas,et al.  Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein. , 2008, The Journal of investigative dermatology.

[26]  M. Dattani,et al.  Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. , 2007, The Journal of clinical endocrinology and metabolism.

[27]  R. Y. Wei,et al.  Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse , 2007, BMC Genomics.

[28]  D. Geiger,et al.  A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. , 2006, American journal of human genetics.

[29]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[30]  E. Lalli,et al.  DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. , 2003, Molecular endocrinology.

[31]  S. Bornstein,et al.  Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Camper,et al.  Role of Ahch in gonadal development and gametogenesis , 1998, Nature Genetics.

[33]  W. Kutteh,et al.  MONOSOMY 7 SYNDROME ASSOCIATED WITH CONGENITAL ADRENAL HYPOPLASIA AND MALE PSEUDOHERMAPHRODITISM , 1996, Obstetrics and gynecology.